Selected research
Market Analysis & Forecast
Global Crisaborole Market Analysis and Forecast 2026-2032
Market perspective
The global Crisaborole market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Crisaborole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Crisaborole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Crisaborole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Crisaborole is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Crisaborole include Neuraxpharm, Tapi Teva, VIRUJ PHARMA, Synergy Pharmaceutical and Ausun Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Crisaborole, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Crisaborole, also provides the sales of main regions and countries. Of the upcoming market potential for Crisaborole, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Crisaborole sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Crisaborole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Crisaborole sales, projected growth trends, production technology, application and end-user industry.
Crisaborole Segment by Company
Neuraxpharm
Tapi Teva
VIRUJ PHARMA
Synergy Pharmaceutical
Ausun Pharmaceutical
Crisaborole Segment by Type
Purity Above 98%
Purity Below 98%
Crisaborole Segment by Application
Allergic Dermatitis
Other
Crisaborole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crisaborole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crisaborole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crisaborole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Crisaborole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Crisaborole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crisaborole sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Allergic Dermatitis
- Other
Companies covered
- Neuraxpharm
- Tapi Teva
- VIRUJ PHARMA
- Synergy Pharmaceutical
- Ausun Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Crisaborole Market by Type
- 1.2.1 Global Crisaborole Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Purity Above 98%
- 1.2.3 Purity Below 98%
- 1.3 Crisaborole Market by Application
- 1.3.1 Global Crisaborole Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Allergic Dermatitis
- 1.3.3 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Crisaborole Market Dynamics
- 2.1 Crisaborole Industry Trends
- 2.2 Crisaborole Industry Drivers
- 2.3 Crisaborole Industry Opportunities and Challenges
- 2.4 Crisaborole Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Crisaborole Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Crisaborole Revenue by Region
- 3.2.1 Global Crisaborole Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Crisaborole Revenue by Region (2021-2026)
- 3.2.3 Global Crisaborole Revenue by Region (2027-2032)
- 3.2.4 Global Crisaborole Revenue Market Share by Region (2021-2032)
- 3.3 Global Crisaborole Sales Estimates and Forecasts 2021-2032
- 3.4 Global Crisaborole Sales by Region
- 3.4.1 Global Crisaborole Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Crisaborole Sales by Region (2021-2026)
- 3.4.3 Global Crisaborole Sales by Region (2027-2032)
- 3.4.4 Global Crisaborole Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Crisaborole Revenue by Manufacturers
- 4.1.1 Global Crisaborole Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Crisaborole Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Crisaborole Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Crisaborole Sales by Manufacturers
- 4.2.1 Global Crisaborole Sales by Manufacturers (2021-2026)
- 4.2.2 Global Crisaborole Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Crisaborole Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Crisaborole Sales Price by Manufacturers (2021-2026)
- 4.4 Global Crisaborole Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Crisaborole Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Crisaborole Manufacturers, Product Type & Application
- 4.7 Global Crisaborole Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Crisaborole Market CR5 and HHI
- 4.8.2 2025 Crisaborole Tier 1, Tier 2, and Tier 3
5 Crisaborole Market by Type
- 5.1 Global Crisaborole Revenue by Type
- 5.1.1 Global Crisaborole Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Crisaborole Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Crisaborole Revenue Market Share by Type (2021-2032)
- 5.2 Global Crisaborole Sales by Type
- 5.2.1 Global Crisaborole Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Crisaborole Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Crisaborole Sales Market Share by Type (2021-2032)
- 5.3 Global Crisaborole Price by Type
6 Crisaborole Market by Application
- 6.1 Global Crisaborole Revenue by Application
- 6.1.1 Global Crisaborole Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Crisaborole Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Crisaborole Revenue Market Share by Application (2021-2032)
- 6.2 Global Crisaborole Sales by Application
- 6.2.1 Global Crisaborole Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Crisaborole Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Crisaborole Sales Market Share by Application (2021-2032)
- 6.3 Global Crisaborole Price by Application
7 Company Profiles
- 7.1 Neuraxpharm
- 7.1.1 Neuraxpharm Company Information
- 7.1.2 Neuraxpharm Business Overview
- 7.1.3 Neuraxpharm Crisaborole Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Neuraxpharm Crisaborole Product Portfolio
- 7.1.5 Neuraxpharm Recent Developments
- 7.2 Tapi Teva
- 7.2.1 Tapi Teva Company Information
- 7.2.2 Tapi Teva Business Overview
- 7.2.3 Tapi Teva Crisaborole Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Tapi Teva Crisaborole Product Portfolio
- 7.2.5 Tapi Teva Recent Developments
- 7.3 VIRUJ PHARMA
- 7.3.1 VIRUJ PHARMA Company Information
- 7.3.2 VIRUJ PHARMA Business Overview
- 7.3.3 VIRUJ PHARMA Crisaborole Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 VIRUJ PHARMA Crisaborole Product Portfolio
- 7.3.5 VIRUJ PHARMA Recent Developments
- 7.4 Synergy Pharmaceutical
- 7.4.1 Synergy Pharmaceutical Company Information
- 7.4.2 Synergy Pharmaceutical Business Overview
- 7.4.3 Synergy Pharmaceutical Crisaborole Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Synergy Pharmaceutical Crisaborole Product Portfolio
- 7.4.5 Synergy Pharmaceutical Recent Developments
- 7.5 Ausun Pharmaceutical
- 7.5.1 Ausun Pharmaceutical Company Information
- 7.5.2 Ausun Pharmaceutical Business Overview
- 7.5.3 Ausun Pharmaceutical Crisaborole Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Ausun Pharmaceutical Crisaborole Product Portfolio
- 7.5.5 Ausun Pharmaceutical Recent Developments
8 North America
- 8.1 North America Crisaborole Market Size by Type
- 8.1.1 North America Crisaborole Revenue by Type (2021-2032)
- 8.1.2 North America Crisaborole Sales by Type (2021-2032)
- 8.1.3 North America Crisaborole Price by Type (2021-2032)
- 8.2 North America Crisaborole Market Size by Application
- 8.2.1 North America Crisaborole Revenue by Application (2021-2032)
- 8.2.2 North America Crisaborole Sales by Application (2021-2032)
- 8.2.3 North America Crisaborole Price by Application (2021-2032)
- 8.3 North America Crisaborole Market Size by Country
- 8.3.1 North America Crisaborole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Crisaborole Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Crisaborole Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Crisaborole Market Size by Type
- 9.1.1 Europe Crisaborole Revenue by Type (2021-2032)
- 9.1.2 Europe Crisaborole Sales by Type (2021-2032)
- 9.1.3 Europe Crisaborole Price by Type (2021-2032)
- 9.2 Europe Crisaborole Market Size by Application
- 9.2.1 Europe Crisaborole Revenue by Application (2021-2032)
- 9.2.2 Europe Crisaborole Sales by Application (2021-2032)
- 9.2.3 Europe Crisaborole Price by Application (2021-2032)
- 9.3 Europe Crisaborole Market Size by Country
- 9.3.1 Europe Crisaborole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Crisaborole Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Crisaborole Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Crisaborole Market Size by Type
- 10.1.1 China Crisaborole Revenue by Type (2021-2032)
- 10.1.2 China Crisaborole Sales by Type (2021-2032)
- 10.1.3 China Crisaborole Price by Type (2021-2032)
- 10.2 China Crisaborole Market Size by Application
- 10.2.1 China Crisaborole Revenue by Application (2021-2032)
- 10.2.2 China Crisaborole Sales by Application (2021-2032)
- 10.2.3 China Crisaborole Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Crisaborole Market Size by Type
- 11.1.1 Asia Crisaborole Revenue by Type (2021-2032)
- 11.1.2 Asia Crisaborole Sales by Type (2021-2032)
- 11.1.3 Asia Crisaborole Price by Type (2021-2032)
- 11.2 Asia Crisaborole Market Size by Application
- 11.2.1 Asia Crisaborole Revenue by Application (2021-2032)
- 11.2.2 Asia Crisaborole Sales by Application (2021-2032)
- 11.2.3 Asia Crisaborole Price by Application (2021-2032)
- 11.3 Asia Crisaborole Market Size by Country
- 11.3.1 Asia Crisaborole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Crisaborole Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Crisaborole Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Crisaborole Market Size by Type
- 12.1.1 SAMEA Crisaborole Revenue by Type (2021-2032)
- 12.1.2 SAMEA Crisaborole Sales by Type (2021-2032)
- 12.1.3 SAMEA Crisaborole Price by Type (2021-2032)
- 12.2 SAMEA Crisaborole Market Size by Application
- 12.2.1 SAMEA Crisaborole Revenue by Application (2021-2032)
- 12.2.2 SAMEA Crisaborole Sales by Application (2021-2032)
- 12.2.3 SAMEA Crisaborole Price by Application (2021-2032)
- 12.3 SAMEA Crisaborole Market Size by Country
- 12.3.1 SAMEA Crisaborole Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Crisaborole Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Crisaborole Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Crisaborole Value Chain Analysis
- 13.1.1 Crisaborole Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Crisaborole Production Mode & Process
- 13.2 Crisaborole Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Crisaborole Distributors
- 13.2.3 Crisaborole Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst